Go back to News
NEWS
Pedro Vilarinho Pires on the decision that may exclude Huawei from 5G | Observador
Observador includes in this article statements from Pedro Vilarinho Pires, Of Counsel of the Competition and European Law area and of the Technology, Media and Telecommunications (TMT) area of the Lisbon office, in the article “A technical or geopolitical decision? 13 questions on the deliberation that may exclude Huawei from 5G”.
Pedro Vilarinho Pires states that “Although it is not a legal issue, the delay in 5G implementation is a possibility that cannot be excluded, namely if the imposed restriction implies the search for replacement equipment and the reconfiguration of networks”.
Pedro Vilarinho Pires states that “Although it is not a legal issue, the delay in 5G implementation is a possibility that cannot be excluded, namely if the imposed restriction implies the search for replacement equipment and the reconfiguration of networks”.
Lawyer mentioned
Pedro Vilarinho – Counsel
Press contact

Sandra Cuesta
Director of Business Development, Marketing and Communications

Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
29 Jul, 2025
The use of personal data to train artificial intelligence systems
The judgment of the Regional High Court (Oberlandesgericht) of Cologne of 23 May 2025 (15 UKl 2/25), in which the German court rejects the application for interim relief prohibiting the defendant from processing personal data published by consumers on Facebook and Instagram for the development and improvement of artificial intelligence systems, is analysed.
PUBLICATION
15 Jul, 2025
Offsetting employment claims: can a company offset them unilaterally?
If a collective action is brought to challenge the unilateral conduct of a company in the offsetting of salary claims through a payroll deduction, the amount of the debt and the existence of quantitative discrepancies must necessarily be questioned in order to be able to assess whether or not there is legal offsetting on the part of the employer. Only by admitting that the debt is a liquidated amount that is due and payable will the employer - or the employee, as the case may be - be able to offset the debt, but if the debt is not disputed, the way is open for the offsetting of wage claims.
PUBLICATION
02 Jul, 2025
Pharma & Healthcare No. 44
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
21 May, 2025
Modification of concession when concessionaire no longer has in-housestatus: the CJEU clarifies when a new award procedure is not required
The Judgment of the Court of Justice of the European Union of 29 April 2025 addresses the modification of public contracts originally awarded to an in-house entity which, during performance of the contracts, has lost such status. The reference for a preliminary ruling was made in the context of a dispute concerning the extension of concession contracts relating to service facilities ancillary to motorways to include the construction, maintenance and operation of fast-charging infrastructure.
PUBLICATION
16 Apr, 2025
Pharma & Healthcare No. 43
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
10 Mar, 2025
Pharma & Healthcare No. 42
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
15 Jan, 2025
New Supreme Court doctrine on the nullity of fuel supply arrangements on grounds of competition law infringements
Analysis of the Supreme Court judgments of 6 and 7 November 2024 establishing a new doctrine on the fixing of retail fuel prices at service stations and on the binding effect of national competition authorities’ decisions on national judges and courts.
PUBLICATION
13 Dec, 2024
Invalidity of franchise providing for franchisor price-setting: implications in terms of restitution
The age-old problem of whether Article 1303 or 1306 of the Civil Code applies to contracts in breach of competition law.
PUBLICATION
26 Nov, 2024
Pharma & Healthcare No. 41
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.